← back to search

Saskia W. C. van Mil

Utrecht University · NL
Area of research
Oncology · Surgery
Research interest
Research interests include Drug Transport and Resistance Mechanisms, Pediatric Hepatobiliary Diseases and Treatments, Liver Disease Diagnosis and Treatment, and Inflammatory Bowel Disease.
h-index
37
citations
7,041
works
80
NIH funding
primary concept
Medicine
email

Recent publications

The farnesoid X receptor activates transcription independently of RXR at non-canonical response elements.
2025cited by 1position: contributordoi
Integrin-TGFβ axis induces partial EMT in basal-like cells to lead collective invasion
bioRxiv (Cold Spring Harbor Laboratory) 2025cited by 0position: middledoi
Development of a metabolic signature of post-weaning diarrhoea in pigs
2025cited by 0position: contributordoi
Human liver organoids: From generation to applications.
2024cited by 24position: contributordoi
Dietary cystine restriction increases the proliferative capacity of the small intestine of mice.
2024cited by 6position: contributordoi
The plasma lipidome varies with the severity of metabolic dysfunction-associated steatotic liver disease.
2024cited by 3position: contributordoi
Human liver organoids: From generation to applications
Hepatology 2023cited by 41position: middledoi
Rifaximin stimulates nitrogen detoxification by PXR-independent mechanisms in human small intestinal organoids.
2023cited by 5position: contributordoi
Issue Cover
Liver International 2023cited by 0position: contributordoi
PPARγ lipodystrophy mutants reveal intermolecular interactions required for enhancer activation
Nature Communications 2022cited by 20position: middledoi
Rifaximin stimulates nitrogen detoxification by <scp>PXR</scp>‐independent mechanisms in human small intestinal organoids
Liver International 2022cited by 11position: lastdoi
PPARγ lipodystrophy mutants reveal intermolecular interactions required for enhancer activation.
2022cited by 11position: contributordoi
Protein Condensation in the Nuclear Receptor Family; Implications for Transcriptional Output.
2022cited by 1position: contributordoi
Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis
Journal of Hepatology 2021cited by 345position: middledoi
Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance
JHEP Reports 2021cited by 45position: middledoi
Post-Translational Modifications of FXR; Implications for Cholestasis and Obesity-Related Disorders
Frontiers in Endocrinology 2021cited by 33position: lastdoi
Ablation of liver Fxr results in an increased colonic mucus barrier in mice
JHEP Reports 2021cited by 22position: lastdoi
Post-Translational Modifications of FXR; Implications for Cholestasis and Obesity-Related Disorders.
2021cited by 22position: contributordoi
Breast milk nutrients driving intestinal epithelial layer maturation via Wnt and Notch signaling: Implications for necrotizing enterocolitis
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2021cited by 21position: lastdoi
Ablation of liver <i>Fxr</i> results in an increased colonic mucus barrier in mice.
2021cited by 18position: contributordoi
Breast milk nutrients driving intestinal epithelial layer maturation via Wnt and Notch signaling: Implications for necrotizing enterocolitis.
2021cited by 16position: contributordoi
Splice variants of metabolic nuclear receptors: Relevance for metabolic disease and therapeutic targeting.
2021cited by 13position: contributordoi
FXR Isoforms Control Different Metabolic Functions in Liver Cells via Binding to Specific DNA Motifs
Gastroenterology 2020cited by 96position: lastdoi
FXR Isoforms Control Different Metabolic Functions in Liver Cells via Binding to Specific DNA Motifs.
2020cited by 76position: contributordoi
MetaboShiny: interactive analysis and metabolite annotation of mass spectrometry-based metabolomics data
Metabolomics 2020cited by 29position: middledoi
[Non-alcoholic fatty liver disease; a full-bodied epidemic].
2020cited by 0position: contributor
Steroidogenic control of liver metabolism through a nuclear receptor-network
Molecular Metabolism 2019cited by 34position: middledoi
Identification of FDA-approved drugs targeting the Farnesoid X Receptor.
2019cited by 19position: contributordoi
Dissecting the allosteric FXR modulation: a chemical biology approach using guggulsterone as a chemical tool
MedChemComm 2019cited by 10position: middledoi
Dissecting the allosteric FXR modulation: a chemical biology approach using guggulsterone as a chemical tool.
2019cited by 5position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

José M. Ramos Pittol · Universität Innsbruck8 papers (2015–2022) · 8 papers (2019–2025)José Miguel Ramos Pittol · University Medical Center Utrecht7 papers (2019–2025)Vittoria Massafra · Utrecht University6 papers (2015–2019)Alexandra Milona · MRC London Institute of Medical Sciences6 papers (2012–2020)Noortje Ijssennagger · Utrecht University6 papers (2015–2021)Boudewijn Burgering · The Netherlands Cancer Institute4 papers (2017–2020)Eric Kalkhoven · Cancer Genomics Centre4 papers (2018–2022)Ellen C.L. Willemsen · University Medical Center Utrecht4 papers (2017–2021)Ulrich Beuers · Academic Center for Dentistry Amsterdam3 papers (2022–2023)Antimo Gioiello · University of Pennsylvania3 papers (2018–2019)Harmjan R. Vos · Utrecht University3 papers (2017–2019)Ingrid T.G.W. Bijsmans · Utrecht University3 papers (2012–2019)Roberto Pellicciari · Bridge Pharma (United States)3 papers (2018–2021)Edwin C. A. Stigter · Analytical Biosciences (China)3 papers (2023–2025)Stefanía Magnúsdóttir · Utrecht University3 papers (2019–2025)Arjen Koppen · Utrecht University2 papers (2018–2022)Marjoleine F. Broekema · Utrecht University2 papers (2018–2022)Sander Kersten · Cornell University2 papers (2022–2022)Stefanía Magnúsdóttir · Utrecht University2 papers (2020–2021)